Difference between revisions of "Kidney cancer staging"
Jump to navigation
Jump to search
Line 17: | Line 17: | ||
*Most cases are pT1a or pT3a. | *Most cases are pT1a or pT3a. | ||
**pT2 is very rare and pT1b is uncommon for [[CCRCC]].<ref name=pmid16145369>{{Cite journal | last1 = Bonsib | first1 = SM. | title = T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. | journal = J Urol | volume = 174 | issue = 4 Pt 1 | pages = 1199-202; discussion 1202 | month = Oct | year = 2005 | doi = | PMID = 16145369 }}</ref> | **pT2 is very rare and pT1b is uncommon for [[CCRCC]].<ref name=pmid16145369>{{Cite journal | last1 = Bonsib | first1 = SM. | title = T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. | journal = J Urol | volume = 174 | issue = 4 Pt 1 | pages = 1199-202; discussion 1202 | month = Oct | year = 2005 | doi = | PMID = 16145369 }}</ref> | ||
***32% of 4.1-7.0 cm CCRCCs are limited to the kidney. | |||
***3% of >7 cm CCRCCs are limited to the kidney. | |||
===Lymph node staging=== | ===Lymph node staging=== |